New COVID vaccines get emergency approval from FDA for 2024-2025 season
The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. The updated mRNA vaccines were “approved and authorized for emergency use,” according to an FDA announcement released today. The monovalent (single) vaccines are designed to target the Omicron variant KP.2 strain of SARS-CoV-2. RISKS ASSOCIATED…
Read More “New COVID vaccines get emergency approval from FDA for 2024-2025 season” »